Clinical Trial Update: Phase Ib Study of Olaparib Plus Weekly Carboplatin and Paclitaxel in Relapsed Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

It reports an ongoing Phase Ib/Phase II trial of olaparib plus weekly carboplatin and paclitaxel in relapsed ovarian cancer. The trial lists Stage III/Stage IV …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Uterine Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Lynparza (olaparib)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Swedish Medical Center | Conditions: Stage III Ovarian Cancer, Stage IV Ovarian Cancer | Phase 1, Phase 2 | Status: UNKNOWN